Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.
Margins expand sequentially by nearly 4 percentage points to 20 percent.
Investors say management maintained revenue guidance of mid-teens growth and 20 percent margins in FY15 in a conference call.
Strong growth in India and better product mix will further aid margins, fund managers add.
Cipla shares were trading up nearly 2 percent to 457.30 rupees as of 11:49 a.m.